PLAY PODCASTS
HITshow Daily: October 2, 2025 (Thursday)
Season 1 · Episode 49

HITshow Daily: October 2, 2025 (Thursday)

HITshow Daily Audio Newscast

October 3, 20259m 11s

Audio is streamed directly from the publisher (media.blubrry.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

Today on HITshow: Today’s top story: the federal shutdown is more than politics — Teresa Vaughn walks providers through a detailed checklist on compliance, telehealth, hospital-at-home, finance, and research. Also: UnitedHealth hires Duke’s AI leader as Chief Scientist, Hackensack pairs dogs with AI for cancer detection, Omada launches a nutrition AI for chronic care, and the federal government calls on Eli Lilly and Pfizer to boost production of key drugs. HOST: Steve Daily 📍 Providers / Government — Teresa VaughnThe shutdown fallout is hitting operations: CMS survey triage, telehealth flex expirations, Hospital-at-Home pause, and looming safety-net cuts. Vaughn shares the following checklist for health system leaders: Quality & Compliance: Focus on IJ, EMTALA, dialysis. Access & Scheduling: Update telehealth workflows for therapy and mental health. Capacity: Reallocate staff and beds with Hospital-at-Home paused. Finance: Model DSH and rural add-on reductions through Q4. Community: Coordinate with FQHCs to smooth referrals. Innovation & Research: Expect device and grant delays; adjust timelines. 📍 AI & Payers — Jade RomeroUnitedHealth names Duke’s Michael Pencina as Chief AI Scientist, signaling a credibility-first push to scale responsible AI. 📍 Providers / Research — Logan StokesHackensack Meridian partners with Israel-based startup SpotitEarly to validate canine scent + AI for early cancer detection — a message to providers that bold research can be a differentiator. 📍 Digital Health — Nate CollierOmada Health debuts “Meal Map,” an AI nutrition tool for cardiometabolic patients — early pilots show engagement gains. 📍 Pharma & Policy — Peter BetterworthThe administration asks Eli Lilly to ramp production of insulin, and Pfizer to increase productoin of Ibrance, and Lipitor — raising supply and formulary planning questions for hospitals. 🎧 Subscribe here or wherever you listen to podcasts, and if you like our show, please follow us on LinkedIn at https://www.linkedin.com/company/hit.show. HITshow is made possible by HLTH 2025.